Treatment of early-stage HER2+ breast cancer-an evolving field

被引:8
|
作者
Ferreira, Arlindo R. [1 ,2 ,3 ]
Saini, Kamal S. [4 ]
Metzger-Filho, Otto [1 ]
机构
[1] Dana Farber Canc Inst, Boston, MA 02215 USA
[2] Univ Lisbon, Hosp Santa Maria, P-1649035 Lisbon, Portugal
[3] Univ Lisbon, Inst Med Mol, P-1649035 Lisbon, Portugal
[4] Univ Libre Bruxelles, Inst Jules Bordet, B-1000 Brussels, Belgium
来源
ECANCERMEDICALSCIENCE | 2015年 / 9卷
关键词
breast neoplasm; trastuzumab; neoadjuvant therapy; adjuvant therapy; antibodies; monoclonal; humanised;
D O I
10.3332/ecancer.2015.523
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The evolving field of HER2-targeted therapy has significantly improved the outcome of women diagnosed with HER2-positive invasive breast cancer. In this review, we sought to summarise the efficacy of trastuzumab-based regimens in the adjuvant and neoadjuvant setting with a special emphasis on relevant clinical questions: treatment duration, sequence of trastuzumab administration, toxicity, the role of anthracycline-based regimens, and optimal management of small HER2+ tumours. Controversial topics are discussed taking into consideration the development of modern anti-HER2 agents.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] News on the medical treatment of young women with early-stage HER2-negative breast cancer
    Lambertini, Matteo
    Poggio, Francesca
    Vaglica, Marina
    Blondeaux, Eva
    Del Mastro, Lucia
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (12) : 1643 - 1655
  • [22] Treatment of Lymph Node-Negative, Early-Stage HER2-Positive Breast Cancer
    Oguz, Arzu
    Keskin, Gul Sema
    Colak, Dilsen
    Altundag, Ozden
    Akcali, Zafer
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (06) : 639 - +
  • [23] Cryotherapy in the Treatment of Early-Stage Breast Cancer
    Ciambella, Chelsey C.
    Takabe, Kazuaki
    WORLD JOURNAL OF ONCOLOGY, 2024, 15 (05) : 737 - 743
  • [24] Treatment of early-stage breast cancer - In brief
    Hurd, TC
    Edge, SB
    Kahlenberg, MS
    Stomper, PC
    Proulx, GM
    Schwartz, G
    Khatri, V
    Winston, JS
    CURRENT PROBLEMS IN CANCER, 1999, 23 (04) : 144 - 228
  • [25] Treatment of early-stage breast cancer - Foreword
    Goulet, RJ
    CURRENT PROBLEMS IN CANCER, 1999, 23 (04) : 142 - 143
  • [26] Personalizing Treatment for Early-Stage Breast Cancer
    Kurian, Allison W.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2023, 30 (12): : 1249 - 1249
  • [27] TREATMENT OF EARLY-STAGE BREAST-CANCER
    HALL, WH
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (03): : 391 - 395
  • [28] Accelerated Partial Breast Irradiation for HER2-Positive Early-Stage Breast Cancer
    O'Brien D.R.
    Boe L.
    Montagna G.
    Mueller B.
    Chino F.
    Cuaron J.
    Choi J.I.
    Xu A.
    Bernstein M.
    McCormick B.
    Powell S.
    Khan A.J.
    Braunstein L.Z.
    International Journal of Radiation Oncology Biology Physics, 2024, 118 (02): : 468 - 473
  • [29] HER2+ breast cancer treatment and cardiotoxicity: monitoring and management
    Guy Jerusalem
    Patrizio Lancellotti
    Sung-Bae Kim
    Breast Cancer Research and Treatment, 2019, 177 : 237 - 250
  • [30] Cardiotoxicity associated with trastuzumab treatment of HER2+ breast cancer
    Fiúza M.
    Advances in Therapy, 2009, 26 (Suppl 1) : S9 - S17